AzTrials
AzTrials

HyperthermiaNCT06142890

Efficacy of Ceiling Fans for Mitigating Thermal Strain During Bed Rest in Older Adults During Heat Waves

A study testing Cooling with ceiling fan in people with Hyperthermia and Heat Stress, run by University of Ottawa at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the increasing regularity and intensity of hot weather and heat waves, there is an urgent need to develop heat-alleviation strategies able to provide targeted protection for heat-vulnerable older adults. Read more about this study

Who is it for?
Ages 65 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Hyperthermia, Heat Stress, Cooling
What is being tested?
Cooling with ceiling fan
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
5 Dec 2023to 10 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Male or female adults.
  • Aged 65-85 years.
  • Non-smoking.
  • English or French speaking.
  • Ability to provide informed consent.

Who cannot join

  • Physical restriction (e.g., due to disease: intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
  • Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable (e.g., medications increasing risk of heat-related illness; beta blockers, anticholinergics, etc.)
  • Cardiac abnormalities identified via 12-lead ECG during an incremental exercise test to volitional fatigue (performed for all participants).
  • Peak aerobic capacity (VO2peak), as measured during an incremental exercise test to volitional fatigue, exceeding the 50th percentile of age- and sex-specific normative values published by the American College of Sports Medicine (ACSM).

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Ottawa

    Ottawa, Ontario, K1N6N5

Other trials in Canada

About this study

Official title: Evaluating the Efficacy of Ceiling Fans for Limiting Heat Strain in Elderly Adults During Bed Rest in an Extreme Heat Event

With the increasing regularity and intensity of hot weather and heat waves, there is an urgent need to develop heat-alleviation strategies able to provide targeted protection for heat-vulnerable older adults. While air-conditioning provides the most effective protection from extreme heat, it is inaccessible for many individuals. Air-conditioning is also energy intensive, which can strain the electrical grid and, depending on the source of electricity generation, contribute to green house gas emissions. For these reasons, recent guidance has recommended the use of electric fans as a sustainable cooling alternative. While fans may increase sweat evaporation and heat loss in healthy, young adults, evidence supporting their use in older adults is scarce. Further, studies show that when environmental temperature exceeds skin temperature, fans are not effective and can even exacerbate hyperthermia in older adults. While older adults only account for ~13% of the population, they account for ~40% off all hospitalizations. In the context of sustainable cooling interventions, this is of particular importance given that many hospitals and long-term care homes do not have air-conditioning and rely on ceiling fans to enhance sweat evaporation while participants are bed-resting. While recent biophysical modelling has suggested that pedestal fans likely provide a clinically meaningful cooling effect (proposed to be ≥0.3°C) in temperatures below ~34°C in older adults, the efficacy of ceiling fans in mitigating heat strain in these conditions is currently unknown.

To address these knowledge gaps, this randomized crossover trial will evaluate body core temperature, cardiovascular strain, orthostatic intolerance, dehydration, and thermal comfort in adults aged 65-85 years exposed for 8-hours to conditions experienced during indoor overheating occurring during a heat wave in a temperate continental climate (31°C, 45% relative humidity). Each participant will complete two randomized exposures that will differ only in the airflow generated by a ceiling fan: no airflow (control) or standard airflow. Participants will remain in a supine position for the duration of the 8-hour exposure period, except for during hour 7 when they will complete a series of cardiovascular autonomic response tests.

Being tested
No cooling (control), Cooling with ceiling fan
Keywords
Heat wave, Cooling intervention, Elderly, Thermoregulation, Cardiovascular strain, Extreme heat event
Medical subject headings
Hyperthermia, Heat Stress Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No cooling (control)Other

    Participants are exposed to 31°C, 45% relative humidity for 8 hours without cooling intervention (control condition). Drinking water is available ad libitum. Participants remain in supine position with slight (~20°) chest and head elevation (low-Fowlers position) throughout the duration of bed-rest exposure.

  • Cooling with ceiling fanOther

    Participants are exposed to 31°C, 45% relative humidity for 8 hours. Drinking water is available ad libitum. Participants remain in supine position with slight (~20°) chest and head elevation (low-Fowlers position) throughout the duration of bed-rest exposure. Participants will remain under a commercially available ceiling fan generating a standard air flow throughout the duration of exposure.

Study groups in NCT06142890
Study groupRoleWhat they receive
No cooling intervention (control)Active comparatorAdults aged 65-85 years with or without type 2 diabetes and/or hypertension
Receives: Other: No cooling (control)
Ceiling fan generating airflowExperimentalAdults aged 65-85 years with or without type 2 diabetes and/or hypertension
Receives: Other: Cooling with ceiling fan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Core temperature (peak)

    Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout each simulated heat wave.

    Measured: End of heat exposure (hour 8)

Secondary outcomes (18)
  1. Core temperature (AUC)

    Area under the curve of rectal temperature (in degree-hours).

    Measured: End of heat exposure (hour 8)

  2. Core temperature (end-exposure)

    Rectal temperature measured at hour 8 of the simulated heat wave exposure (15-min average)

    Measured: End of heat exposure (hour 8)

  3. Heart rate (peak)

    Peak heart rate (15 min average) during exposure. Heart rate is measured continuously via 3-lead ECG throughout each simulated heat wave

    Measured: End of heat exposure (hour 8)

  4. Heart rate (end-exposure)

    Heart rate measured at hour 8 of the simulated heat wave exposure (15-min average)

    Measured: End of heat exposure (hour 8)

  5. Heart rate (AUC)

    Area under the curve of rectal temperature (total beats).

    Measured: End of heat exposure (hour 8)

  6. Cardiac Response to Standing From Supine (30:15 Ratio)

    Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

    Measured: During heat exposure (hour 7)

  7. Systolic Response to Standing From Supine

    Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

    Measured: During heat exposure (hour 7)

  8. Systolic blood pressure

    Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

    Measured: End of heat exposure (hour 8)

  9. Diastolic blood pressure

    Diastolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

    Measured: End of heat exposure (hour 8)

  10. Rate pressure product (end-exposure)

    Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.

    Measured: End of heat exposure (hour 8)

  11. Heart rate variability: SDNN (end-exposure)

    Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

    Measured: During heat exposure (hour 7)

  12. Heart rate variability: RMSSD (end-exposure)

    Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

    Measured: During heat exposure (hour 7)

  13. Fluid consumption

    Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

    Measured: End of heat exposure (hour 8)

  14. Whole-body sweat rate

    Average hourly whole-body sweat rate calculated as the change body mass during each exposure presented as a percentage of baseline body mass (corrected for food/water consumption and urination and normalized to the exposure duration)

    Measured: End of heat exposure (hour 8)

  15. Fluid loss

    Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption)

    Measured: End of heat exposure (hour 8)

  16. Change in plasma volume

    Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill.

    Measured: End of heat exposure (hour 8)

  17. Thermal comfort scale (end-exposure)

    Thermal comfort assessed via a visual analog scale ("How comfortable does your body temperature feel?") ranging from "extremely uncomfortable" to "extremely comfortable"(midpoint: neutral).

    Measured: End of heat exposure (hour 8)

  18. Orthostatic intolerance symptoms assessment

    Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the lying to standing tests. All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort".

    Measured: During heat exposure (hour 7)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2023
  2. Study start5 Dec 2023
  3. Primary completion10 Feb 2024
  4. Study completion10 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will complete 2 simulated heat wave exposures in random order: i) bed-rest; no fan cooling (control) and ii) bed-rest positioned beneath a ceiling fan providing standard air flow.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06142890
Sponsor's protocol ID
H-11-21-7575
Status last verified
Feb 2025
First submitted
13 Nov 2023
Last updated
20 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified participant data will be made available with approved analysis plan and signed access agreement

Publications

  • McGarr GW, O'Connor FK, Kenny GP. Effects of Ceiling Fans on Self-Reported Symptoms and Mood-State in Bed-Resting Older Adults Exposed to Indoor Overheating. J Am Geriatr Soc. 2026 Jun;74(6):1703-1708. doi: 10.1111/jgs.70388. Epub 2026 Mar 15.

    PubMed 41833559
  • O'Connor FK, Meade RD, Janetos KT, Li-Maloney C, Sigal RJ, Boulay P, Kenny GP. Effect of Ceiling Fans on Core Temperature in Bed-Resting Older Adults Exposed to Indoor Overheating. J Am Geriatr Soc. 2026 Jan;74(1):200-204. doi: 10.1111/jgs.70109. Epub 2025 Sep 27.

    PubMed 41014079

Questions about this trial

What is this clinical trial studying?

A study testing Cooling with ceiling fan in people with Hyperthermia and Heat Stress, run by University of Ottawa at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Core temperature (peak) (time frame: End of heat exposure (hour 8)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06142890, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in